InvestorsHub Logo

sentiment_stocks

08/28/15 9:56 PM

#39587 RE: Ready4bluesky #39586

Now that's some excellent processing.

It would be nice to hear from Larry. He did say he would "like to an update" when he got back.

It'd be interesting to see what he thinks of all this.

mapman1010

08/28/15 10:32 PM

#39589 RE: Ready4bluesky #39586

Ready, I totally agree;

I suppose it would have been easy enough for them to rule out any safety concerns in the PR. However, it would make sense that they are being very careful not to tip their hand on ‘positive’ developments in the trial. My guess is that there are very specific rules and procedures to maintain the trial integrity before or during a regulatory review.



i have been investing in biotechs for many years and it is my opinion that ever since Woodford became involved NWBO has been playing it by the book with respect to the FDA and the scientific community. the main contention the scientific community and the naysayers (bloggers and short sellers) had with NWBO and LP was that the company was over promoting. In a private correspondence with a colleague of Linda Liau, who knows her personally and has been published as a co-author of papers and abstracts about the immune system, i asked his opinion of NWBO. After the salutations his first response was about how he believed the company was over promoting. this was over a year ago and before Woodford became involved.
I have no problems with how NWBO has handled this situation and i believe very good things are in the works.